Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children
Status:
Completed
Trial end date:
2000-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if it is safe and effective to give an anti-HIV drug
combination of indinavir (IDV) plus stavudine (d4T) plus lamivudine (3TC) to HIV-infected
children. IDV will be given either as a powder mixed into applesauce or as capsules given on
an empty stomach.
Phase:
Phase 1
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)